Markets
BSE See NSE See 27,782.25
-53.66 (-0.19%)

Five Stars of India Inc.

| 2/23/2012 9:30 PM Thursday

December 2011 was an eventful quarter for India Inc. Be it on the global front or on the domestic front, every now and then certain events kept investors busy. On the global front, the European debt crisis and slower-than-expected growth in the US markets kept everyone on their toes. On the domestic side, the sharp depreciation of the rupee (eight per cent) against the US dollar, inflation worries and the worst-ever IIP numbers (negative 5.10 per cent in October 2011) made sure that India Inc. did not get any respite. What added to the woes was the government inefficiency that led to policy paralysis. While these were the major negative factors, the biggest positive news came in when the RBI took a pause on the rate hike front.

All in all, it was a mixed quarter, and the corporate results too were on similar lines. Expectations on the corporate performance front were already low from the December 2011 quarter on account of the negative factors mentioned above, even after considering the higher base of the corresponding quarter (QE December 2010).

If we take a look at the results for the December 2011 quarter, they appear to be neither good nor bad. Rather, they are very much as they were expected to be. We analysed the results of 3706 companies, and at the gross level the outcome suggests that the for QE December 2011, topline growth came in at around 26 per cent while bottomline growth was around 43 per cent as compared to the December 2010 quarter.

India Inc.'s Performance (Excluding Refineries) (Rs. Cr)
ParticularsDec 2011 QuarterDec 2010 Quarter% Change
Sales 1207110 982426 23
Operating Profit 306431 263539 16
Interest 157057 108080 45
Extraordinary Items 1209 778 55
PBT 146173 148946 -2
PAT 94676 101481 -7

The 43 per cent bottomline growth may look surprising to many, particularly because we mentioned right at the outset that the results appear to be neither good nor bad. However, a deeper scrutiny of the data reveals that the profits were skewed due to higher earnings from Oil Marketing Companies and also on account of extraordinary income; aberrations that need to be considered while looking at the growth that came in at the bottomline level.

As a standard practice, we adjusted for both these factors and arrived at the true picture after doing so. This shows a topline growth of 23 per cent and a decline in net profit by around 7.20 per cent as compared to the December 2010 quarter. On a sequential basis, the topline grew by six per cent and there was a marginal increase of 1.50 per cent on the bottomline front.

If we take a look at the results, a few factors emerge straight away. First, the raw material prices remained firm despite many expecting some amount of easing in December 2011. Higher raw material prices that could not be passed on to customers impacted the operating margins, which witnessed a decline of around 150 basis points and stood at 25.40 per cent. We are of the opinion that the high cost inventories that were carried forward might be the reason behind the same, and we may witness some improvement on the margins front in the coming quarters.

Find More Articles on: DSIJ Magazine, Cover Story, Markets, Market Outlook

«« First « Previous |1 2 3 4 ... 8 9 10 11 12 13 14 | Last ››
collapse Related Readings collapse

DSIJ
Mindshare

IT & Pharma Funds under-perform

IT & Pharma Funds  under-perform

Going ahead, investing in Pharma Funds may be a good idea with several analysts being bullish on the sector's growth. Rich valuation may be a limitation when it comes to investing in stocks in Pharma sector.

R Comm and Aircel to buddy up soon

R Comm and Aircel to buddy up soon

Reliance Communications' and Aircel's merger is in the final lap of getting cleared. Reliance Communications which was waiting for a nod from the Department of Telecom (DOT) is now  relieved.

Overnight Digest – Stocks to look out for on August 29

Overnight Digest – Stocks to look out for on August 29

The stocks which could witness a significant movement on August 29 are Capital Trust, Trident, IOC, Alankit and DLF.

Welspun's loss becomes Trident gain

Welspun's loss becomes Trident gain

‘One man’s trash another man’s treasure' is an idiom that somewhat resembles the situation in which Trident is right know sailing. The BSE 500 stock on Aug 26 has emerged as the top gainer on the bourses surging by more than 10 per cent. 

Indices struggled; Tata Motors surges

Indices struggled; Tata Motors surges

The bears have been active from last three consecutive days and the Indian markets are struggling to breakout. In first day of F&O trade, Banking, Healthcare, IT and Capital Goods indices closed on a negative note. The Nifty ended lower by 19 points at 8572; and Sensex was 53 points down at 27782. The indices lost -0.31 to -0.19 per cent respectively.

Tata Motors ends in green despite of weak Q1FY17

Tata Motors ends in green despite of weak Q1FY17

Tata Motors has declared its Q1FY17 results on Friday. The company’s revenue has increased by 9.02 per cent to Rs 67056 crore in Q1FY17 as compared to same period in previous fiscal.

Mid-market commentary Aug 26

Mid-market commentary Aug 26

Indian markets opened on a positive note but retreated from the very moment to trade in red, continuing with its previous fall. Markets have seen gradual lower tops and lower bottoms in the intraday trade. Broader markets are flat.

Abbott India witnesses incremental revenue in Q1FY17

Abbott India witnesses incremental revenue in Q1FY17

Abbott India has declared its Q1FY17 results on Friday. The company’s revenue has increased by 15.83 per cent to Rs 738 crore in Q1FY17 as compared to same period in previous fiscal. 

Top Gainers and Losers of mid-day

Top Gainers and Losers of mid-day

Following are the top gainers and losers list of Aug 26 as on 12.00 pm.  Trident and ICRA are up by double digits’ gainers. Trident has largely rallied on the news that Target Corp is considering to give order of bed sheets to Trident, were as Jaypee Infratech is the largest loser for the day. 

Medicate your portfolio with Pharma stocks

Medicate your portfolio with Pharma stocks

Pharmaceutical industry is a knowledge intensive industry, and faces its own share of challenges.  India is a leading and most favoured supplier of formulations to advanced markets such as US, Europe and semi regulated markets like Africa, LATAM (Latin America).

Subscribe to
Newsletter

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
debajyoti roy Aug 27 09:58PM
All the Stock return 20% within 1 year
Rohit sharma Aug 27 09:27AM
Sachin Koshti @ 9.15am to 3.30pm Monday to friday
mrinmay sandhyaki Aug 27 03:10AM
oooooonoo
naliniprava mahakul Aug 26 08:53PM
Buy Dishman@174/SL-166/Tgt-194/
Mahesh Sontakke Aug 26 07:48PM
i have sold out profit share now waiting loss share to gain it